r Intestinal ischaemia causes epithelial death and crypt dysfunction, leading to barrier defects and gut bacteria-derived septic complications.
Introduction
Intestinal ischaemia/reperfusion (I/R) injury is a pathological condition seen in clinical cases of necrotizing enterocolitis, mesenteric artery embolism, and traumatic and haemorrhagic shock, as well as in patients undergoing major cardiovascular and abdominal surgery (Debus et al. 2011; Eltzschig et al. 2014) . Enteric bacterial translocation and septic complications are observed following epithelial barrier damage in mesenteric I/R insults (Hsiao et al. 2009) . At the cellular level, metabolic and oxidative stresses are caused by ischaemia as a result of a loss of oxygen and nutrient supply, and are exacerbated by a burst of free radicals upon blood reperfusion (Vanlangenakker et al. 2008) . Both types of epithelial cell death (i.e. apoptosis and necrosis) accompanied by villous tip sloughing and crypt dysfunction were documented in mesenteric I/R (Shah et al. 1997; Little et al. 2003; Azuara et al. 2005; Huang et al. 2011) .
Although key regulating proteins for epithelial apoptosis and anti-apoptotic signalling have been studied extensively (Huang et al. 2011; Cheng et al. 2013; Schulz et al. 2013) , there is an apparent lack of knowledge on the molecular machinery for cell necrosis and anti-necrotic factors upon ischaemic challenge. Necrosis has been traditionally considered as an unregulated form of cell death characterized by mitochondrial swelling, subcellular organelle breakdown and plasma membrane explosion. An alternative form of programmed cell necrosis, termed necroptosis, was recently identified that involves phosphorylation and complex formation of receptor-interacting protein (RIP)1/3 and mitochondrial free radical synthesis (Temkin et al. 2006; Cho et al. 2009; Declercq et al. 2009; He et al. 2009; Zhang et al. 2009 ). RIP1/3-mediated necroptosis in intestinal epithelial cells has been documented in murine models of experimental enterocolitis and in patients with inflammatory bowel disease (Gunther et al. 2011; Welz et al. 2011; Pierdomenico et al. 2014) , as well as in in vitro epithelial cell cultures exposed to hypoxic stress or cytotoxic stimulation (Chakrabarti et al. 2003; Kalischuk et al. 2007; Huang et al. 2013) . Recently, necroptosis was reported in ischaemic brain, kidney and heart models (Liang et al. 2014; Luedde et al. 2014; Yin et al. 2015) . It remains unclear whether RIP signals are involved in mechanisms of intestinal ischaemia-induced epithelial necrosis and whether cytoprotective pathways exist to inhibit necroptosis in the gut.
Dual routes of nutrient supply (haematologic and dietary sources) and dynamic epithelial restitution along the crypt-villus axis are unique characteristics of the intestinal tract. Previous studies have demonstrated that glucose uptake inhibited morphological injury and epithelial apoptosis caused by mesenteric I/R (Kozar et al. 2002; Huang et al. 2011) and repressed cell necroptosis triggered by hypoxia (Huang et al. 2013) . Moreover, glucose supplementation also prevented the loss of crypt proliferation following I/R insults (Huang et al. 2011) . Although gut protection by glucose has been generally assumed to be related to energy replenishment, other mechanisms were identified, such as activation of anti-apoptotic phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B (NF-κB) signals, as well as scavenging of mitochondrial oxidative free radicals by glucose metabolites (Yu et al. 2005; Palazzo et al. 2008; Yu et al. 2008; Huang et al. 2011; Huang et al. 2013) . Intracellular glucose undergoes anaerobic glycolysis to generate pyruvate that feeds into the tricarboxylic acid cycle in mitochondrial respiration for oxygen-dependent energy production (Fleming et al. 1997; Fink, 2010) . Pyruvate per se also acts as a free radical scavenger via non-enzymatic reactions and inhibits I/R-induced mucosal injury (Cicalese et al. 1996; Sims et al. 2001; Fink, 2010; Kao & Fink, 2010) . To date, the protective roles of glucose metabolites (i.e. pyruvate and ATP) on epithelial cell death and crypt dysfunction in ischaemic tissues remain incompletely understood.
The present study aimed to investigate whether RIPdependent necroptosis are involved in ischaemia-induced mucosal injury and whether enteral glucose uptake protects against epithelial cell death and restores crypt proliferation via distinct metabolic products.
Methods

Animal models of intestinal ischaemia (Isch) and ischaemia/reperfusion (I/R)
All animal protocols used in the present study were approved and monitored by the Institutional Animal Care and Use Committee in National Taiwan University. Male Wistar rats (250-300 g) were fasted overnight with free access to water and subjected to sham operation, mesenteric Isch or I/R challenge as described previously (Hsiao et al. 2009; Huang et al. 2011; Lu et al. 2012) . After anaesthetization with urethane (1.2 g kg -1 , I.P.; Sigma, St Louis, MO, USA) and confirmation with a lack of toe withdrawal reflex in each animal, rats were subjected to midline laparotomy. Isch rats were subjected to occlusion of the superior mesenteric artery (SMA) with an atraumatic microvascular clamp for 20 min and killed. In I/R rats, the clamp was then released for 60 min before death. Sham-operated control rats received mock manipulation of SMA and were killed after the same period of time. The anaesthesia and surgical procedures comply with the animal ethics checklist of with The Journal of Physiology.
Experimental design
The surgical procedures were carried out under aseptic conditions. After anaesthetization, a 10 cm jejunal sac was created by thread ligature at both ends, beginning 10 cm distal to the ligament of Treitz in each animal as described previously (Hsiao et al. 2009; Huang et al. 2011) . A 1 mL syringe with a PE-10 catheter was intubated to one end of the jejunal sac and 0.5 mL of Krebs buffer with the following substances (see below) was carefully injected into the lumen. Animals were then subjected to sham operation, Isch, or I/R as stated above.
In the first set of experiments investigating epithelial necrosis by mesenteric ischaemia, rats were randomly assigned to four groups (n = 6-8 per group): Group 1, 'CON + Veh' rats that underwent laparotomy and whose jejunal lumen was instilled with Krebs buffer vehicle (Veh) before sham operation; Group 2, 'CON + Nec1' rats that were enterally administered 500 μM necrostatin-1 (Nec1, a specific RIP1 inhibitor) in Krebs buffer 20 min before sham operation; Group 3, 'Isch + Veh' rats that were enterally instilled with Krebs buffer before SMA occlusion for 20 min; and Group 4: 'Isch + Nec1' rats that were enterally administered 500 μM Nec1 in Krebs buffer immediately before SMA occlusion for 20 min.
In the second set of experiments, Isch rats were enterally given 25 mM of glucose or cell-permeable ethyl pyruvate (Huang et al. 2013) in the absence or presence of glucose transporter inhibitors in the jejunal sac. An sodium/glucose transporter 1 (SGLT1) inhibitor phloridzin (2.5 mM) or a glucose transporter 2 (GLUT2) inhibitor phloretin (2.5 mM) was added to the glucose solution to confirm the transporter involved. Additionally, Isch rats were enterally administered empty liposomes or ATP-encapsulated liposomes synthesized by Dr Chin-Tin Chen (Peng et al. 2015) . The concentration of ATP loaded in liposomes was 6.6 mM, as determined by using a commercial ATP assay kit (Invitrogen, Grand Island, NY, USA). All reagents were purchased from Sigma, except the lipids, which were purchased from Avanti Polar Lipids (Birmingham, AL, USA).
In the next set of experiments, rats were subjected to sham-operation (Sham) and I/R challenge with or without enteral glucose or pyruvate (25 mM). In some groups, enteral glucose was replaced by equimolar concentrations of 3-O-methyl-glucopyranoside (3-OMG; a non-metabolizable sugar analogue taken up by glucose transporters), mannitol (a non-absorbable and non-metabolizable sugar used as an osmolarity control) or glutamate (an amino acid used as an oxidative fuel control) before I/R challenge. All reagents were purchased from Sigma.
Measurement of pyruvate and ATP contents
Intestinal segments were excised and luminal contents gently rinsed off. Scraped mucosal lysates were used for the assessment of intracellular pyruvate (Biovision, Milpitas, CA, USA) and ATP levels (Invitrogen) using commercial assay kits in accordance with the manufacturer's instruction (Huang et al. 2013) .
Histopathological scoring
Jejunal segments were fixed in 4% paraformaldehyde and processed for paraffin embedding, and sections of 4 μM thickness were stained with haematoxylin and eosin. The degree of intestinal injury was evaluated using a light microscope and graded by two independent blinded observers based on a previously established scoring system (Huang et al. 2011; Lu et al. 2012 ).
Immunoprecipitation of RIP1-RIP3 complex and the in vitro kinase assay Scraped jejunal mucosa was homogenized in ice-cold complete RIPA buffer [1% Nonidet P-40, 0.25% sodium deoxycholate, 10 mM NaF, 5 mM Na 3 VO 5 , 1 mM phenylmethanesulphonyl fluoride and one tablet of Complete-Mini protease inhibitors cocktail (Roche, Penzberg, Germany) added to 7 ml of buffer immediately before use]. The lysates were centrifuged at 14,000 g J Physiol 595.2 for 10 min and the protein concentration of the supernatant was adjusted to 5 mg ml -1 . After pre-cleaning with recombinant protein G agarose beads (Invitrogen), the RIP1 protein was immunoprecipitated with anti-human RIP1 (BD Bioscience, Franklin Lakes, NJ, USA) overnight at 4°C. The protein-antibody complexes were then incubated with protein G agarose beads for 1 h at 4°C followed by centrifugation at 14,000 g at 4°C and washing with lysis buffer twice. The pellet was dissolved in 2 × electrophoresis sample buffer containing 2% (w/v) SDS, 100 mM dithithreitol and 62.5 mM Tris/HCl (pH 6.8) at a ratio of 1:1, and subjected to 95°C in a heat block for 5 min for denaturation. Samples were used for immunoblotting of RIP3.
The immune complexes were subjected to reducing SDS-PAGE (4-10% polyacrylamide). The resolved proteins were then electroblotted onto Hybond-P polyvinylidene fluoride membranes (Amersham Biosciences, Piscataway, NJ, USA). After blocking for 1 h at room temperature in 5% non-fat dry milk, the membranes were incubated with anti-RIP1 (1:1000; BD Bioscience) or polyclonal rabbit anti-RIP3 (1:1000; Abcam, Cambridge, UK) as the primary antibody overnight. Membranes were washed twice with Tris-buffered saline with 0.1% Tween 20 for 5 min, and incubated with secondary goat anti-rabbit or anti-mouse IgG conjugated with horseradish peroxidase (1:1000; Cell Signaling, Denver, MA, USA) at room temperature for 1 h. The antigens were revealed and the band density was quantified by photoimaging analysis (Huang et al. 2013) .
Scraped mucosa to be processed for in vitro kinase assays were lysed with kinase lysis buffer (20 mM Hepes, 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 5 mM NaF, 0.2 mM Na 3 VO 4 , 1 mM phenylmethanesulphonyl fluoride and Complete-Mini protease inhibitors cocktail) followed by immunoprecipitation by anti-RIP1-conjugated beads as described above. The bead pellets were then incubated in kinase reaction buffer (20 mM Hepes, 5 mM MgCl 2 and 5 mM MnCl 2 ) supplemented with 10 μM cold ATP and 1 μCi γ-32 P-ATP for 30 min at 30°C. The reaction was terminated by adding the same volume of 2 × SDS sample buffer and heat denaturation at 95°C for 5 min, followed by vortex and centrifugation. Samples were resolved on 4-8% SDS-PAGE and exposed to autoradiographic films as described previously (Huang et al. 2013) .
Terminal deoxynucleotidyl transferase dUTP-biotin nick end labelling (TUNEL) staining
Intestinal tissues fixed in 4% paraformaldehyde was sectioned for TUNEL by using a DNA fragmentation detection kit (Merck, Darmstadt, Germany) (Wu et al. 2011; Kuo et al. 2015) . The percentage of TUNEL-positive epithelial cells per villus was calculated from 10 sections from each animal group.
Ussing chamber study
Muscle-stripped intestinal segments were mounted in Ussing chambers (WPI Instruments, Sarasota, FL, USA) for measurement of electrophysiological values including potential difference (PD), short-circuit current (I sc ) and tissue conductance as described previously (Huang et al. 2011; Chen et al. 2013) .
Transmission electron microscopy
Intestinal tissues were fixed in 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 6-8 h at 4°C. After washing in the buffer, tissues were impregnated with 1% osmium teraoxide for 1 h, dehydrated through a graded series of ethanol, and embedded in epoxy resin. Thin sections (70 nm) were cut, stained with uranyl acetate and lead citrate, and examined using an electron microscope (model 7100; Hitach, Tokyo, Japan) equipped with a digital system at 80 kv Yu et al. 2014 ).
Immunohistochemical and immunofluorescence staining
Intestinal tissue sections for immunostaining were processed as described previously (Huang et al. 2011; Kuo et al. 2015) . Briefly, tissue sections were blocked with 2% normal goat serum, and incubated with primary antibodies to proliferating cell nuclear antigen (PCNA) (dilution 1:100; Lifespan Biosciences, Seattle, WA, USA), Ki67 (dilution 1:100; Abcam, Cambridge, UK) or isotype controls. After washing with phosphate-buffered saline, tissues stained for PCNA were incubated with horseradish peroxidase-conjugated anti-rabbit IHC detection reagent (Cell Signaling) and developed with a 3,3 -diaminobenzidine peroxidase substrate followed by counterstaining with haematoxylin. For Ki67 staining, tissues were incubated with Alexa 488-conjugated secondary antibodies (dilution 1:1000; Invitrogen) and stained with a Hoechst dye to visualize cell nuclei. The slides were mounted with aqueous mounting media and viewed under a fluorescence microscope (Carl Zeiss, Oberkochen, Germany).
To quantify cell proliferation in intestinal tissues, the numbers of Ki67-positive cells per crypt were calculated from 18-25 well-oriented crypts in longitudinal view from each animal and a total of six rats per group were used.
Fluorescein-based gut permeability assay
The 4 kDa fluorescein isothiocyanate-conjugated dextran (FD4; Sigma) dissolved in Krebs buffer was administered into the lumen of ligated jejunal sac to a final concentration of 0.5 mg ml -1 immediately after the release of the artery clamp, and arterial plasma from 0.5 ml of blood was taken at 60 min post-reperfusion as described previously (Huang et al. 2011) .
Magnetic resonance imaging (MRI)-based gut permeability assay
To assess real-time gut permeability in vivo, the contrast agent gadodiamide (Gd; Omniscan; GE Healthcare, Little Chalfont, UK) was instilled into the lumen of the ligated jejunal sac to a final concentration of 0.25 M immediately after the release of the artery clamp, and the signal intensity of this agent in the liver and plasma was quantified using MRI as described previously (Hsiao et al. 2009; Huang et al. 2011) .
Analysis of bacterial translocation
The liver and spleen tissues were homogenized, sonicated and adjusted to a protein concentration of 0.1 g ml -1 with sterile phosphate-buffered saline. Each homogenate was inoculated onto fresh blood agar plates (200 μl per plate; Scientific Biotech Corp., Taipei, Taiwan) and the plates were incubated at 37°C overnight. The number of bacterial colony forming units was normalized per gramme of tissue [(colony forming unit) CFU g -1 ] (Hsiao et al. 2009; Huang et al. 2011 ).
Statistical analysis
All values except for bacterial CFU g -1 were expressed as the mean ± SEM and the means were compared by one-way analysis of variance followed by a Student-Newman-Keul test. For the bacterial translocation data, pairwise ranking of the median of CFU g -1 values was conducted using the non-parametric Mann-Whitney U test. P < 0.05 was considered statistically significant.
Results
Mesenteric ischaemia caused RIP-dependent necroptosis in intestinal epithelial cells
Previous studies have reported epithelial apoptosis and villus denudation in I/R rat intestines (Huang et al. 2011; Lu et al. 2012) . To investigate necroptotic signals on the epithelium-covered villus surface, mucosal tissues were collected immediately following mesenteric ischaemia for 20 min. Moreover, Nec1 (a specific RIP1 inhibitor) or vehicle were administered prior to Isch challenge to examine the role of RIP signalling. Formation of RIP1-RIP3 complex and phosphorylation of RIP1 were observed in the jejunal mucosa of Isch rats, as indicated by immunoprecipitation blotting and 32 P kinase radioassays (Fig. 1A) . Necrotic features of jejunal mucosa and an increased histopathological score were observed in Isch rats compared to control groups ( Fig. 1B  and 1C ). Administration of Nec1 alleviated the villus necrotic features and decreased the histopathology score of ischaemic tissues ( Fig. 1B and 1C ). Mesenteric ischaemia also reduced the PD and I sc of jejunal tissues, and resulted in the trend for an increase in tissue conductance (Fig. 1D-F) . Administration of Nec1 partly restored the PD and I sc to baseline levels but did not decrease tissue conductance (Fig. 1D-F) .
Electromicroscopic imaging revealed an abnormal cellular morphology and enlarged subepithelial spaces of ischaemic enterocytes, in marked contrast to the normal columnar epithelial cells with a highly ordered brush border in control tissues ( Fig. 2A) . Subcellular necrotic features and organelle destruction were observed, including mitochondrial swelling, cytoplasmic vacuolation, microvilli in microsomal shapes and plasma membrane disintegration (Fig. 2B-D) . In enterocytes of Isch rats administered with Nec1, no sign of subcellular organelle damage was observed and the cellular morphology was comparable to that of normal controls ( Fig. 2A and 2B ).
Enteral glucose uptake prevented ischaemia-induced epithelial necroptosis
Our previous study had shown that enteral glucose instillation protected against epithelial cell apoptosis in I/R intestine (Huang et al. 2011) . In the present study, we examined whether glucose uptake prevents RIP-dependent necroptotic death in enterocytes of Isch rats. Enteral instillation of glucose ablated mucosal RIP1/RIP3 complex formation and RIP1 phosphorylation (Fig. 3A) and alleviated villous necrotic features and histopathological damage in ischaemic tissues ( Fig. 3C  and 3D ).
SGLT1 is the main apical transporter for dietary glucose, whereas GLUT2 is responsible for basolateral diffusion of glucose into the bloodstream (Scheepers et al. 2004) . To identify the glucose transporters involved in cytoprotection, specific inhibitors were added into the glucose solution during ischaemic challenge. SGLT1-sensitive phloridzin blocked the glucose protection against morphological damage in intestinal mucosa, whereas GLUT2-sensitive phloretin had no effect ( Fig. 3C  and 3D ).
Glycolytic pyruvate attenuated epithelial cell death in an energy-independent manner
To further clarify the glucose metabolites involved in cytoprotection against ischaemic injury, ATP and pyruvate content in mucosal tissues of Isch rats was quantified. A J Physiol 595.2 significant reduction of mucosal ATP and pyruvate levels was seen in ischaemic tissues compared to controls. Enteral instillation of glucose prevented the drop of both ATP and pyruvate levels in mucosal tissues ( Fig. 3E and 3F) .
Because pyruvate and ATP are both final glycolytic products and none of the available inhibitors to glycolytic enzymes are able to differentiate between the synthesis of two substances, blockade studies to the metabolic pathways were not applied in our experimental design. Instead, a cell-permeable pyruvate (ethyl pyruvate) was instilled into the intestinal lumen in an equimolar concentration in place of glucose to confirm its cytoprotective role in Isch rats. Our results showed that pyruvate instillation attenuated RIP1/3-dependent Isch rats were subjected to occlusion of superior mesenteric artery for 20 min with or without Nec1, and jejunal mucosal tissues were processed for electromicroscopy. A, representative electromicrographs of jejunal epithelial cells in CON and Isch rats administered Nec1. Compared to normal columnar epithelial cells with lumen (L)-facing long brush border (BB) in control rats, the enterocytes in ischaemic groups exhibited abnormal morphology, including deformed microvilli and enlarged subepithelial spaces as a result of widened cell-matrix gaps ( # ). The cell nucleus (N) is also labelled. The epithelial morphological damage caused by ischaemia was ameliorated by Nec1. B, higher magnification showed orderly packed microvilli with actin cores rooted on the terminal web (TW), as well as mitochondria (M) organelles with cristae ultrastructure in control enterocytes. Aberrant microsome formation of the microvilli, loss of TW, mitochondrial swelling and cytoplasmic vacuolation ( * ) were noted in ischaemic groups. The ultrastructural abnormality in epithelial cells was ablated by administration of Nec1. C, enterocytes were dissociated from extracellular matrix in the basolateral side (BL), showing widened cell-matrix gaps ( # ) in ischaemic groups. Moreover, reduced density of the cytoplasm (ˆ) was also evident in ischaemic cells. D, cellular fragments showing vacuoles ( * ) surrounding the nucleus (N) and an absence of subcellular organelles as a result of the loss of plasma membrane in ischaemic groups. J Physiol 595.2 necroptosis in the epithelium, and also improved the villus necrotic features and mucosal histopathological scores (Fig. 3B-D) . However, unlike glucose, pyruvate did not increase the mucosal ATP levels during ischaemia, suggesting that pyruvate-mediated death resistance may be exerted through an energy-independent process (Fig. 3E) .
Next, the role of pyruvate in glucose protection against crypt dysfunction was examined. Ischaemic tissues displayed decreased levels of epithelial proliferation as indicated by a reduction in PCNA and Ki67 immunoreactivity in the crypt regions ( Fig. 4A and B) . Enteral instillation of glucose increased crypt PCNA and Ki67 staining in ischaemic intestines, whereas pyruvate instillation did not ( Fig. 4A and B) . Quantification results showed that ischaemia caused a reduction in the number of Ki67-positive cells per crypt, and this phenomenon 
. Enteral instillation of glucose or pyruvate protected against RIP-dependent epithelial necroptosis in ischaemic gut
Control (CON) and Isch rats were enterally instilled with glucose (G), pyruvate (Pyr) or vehicle (veh) to examine the anti-necrotic effects. A and B, immunoprecipitation blotting showed that enteral glucose or pyruvate prevented the formation of RIP1-RIP3 complex and phosphorylation of RIP1 in the jejunal mucosa of Isch rats. The experiments were repeated twice and similar results were obtained (n = 3 per group). C, representative photoimages of the histological changes in CON and Isch rat intestines given glucose or pyruvate. Enteral glucose or pyruvate alleviated the ischaemia-induced mucosal damage and villous destruction. Administration of phloridzin (PHZ; a SGLT1 inhibitor) but not phloretin (PHT; a GLU2 inhibitor) abolished glucose protection. Magnification 200×. D, histopathological scores in the jejunal tissues of CON and Isch rats administered various substrates. * P < 0.05 vs. 'Isch + G' (n = 6 per group) E, intracellular ATP levels in ischaemic gut tissues. F, pyruvate levels in gut mucosa. * P < 0.05 vs. CON, # P < 0.05 vs. 'Isch + Veh' (n = 6 per group). [Colour figure can be viewed at wileyonlinelibrary.com]
was reversed by instillation of glucose but not pyruvate (Fig. 4C ).
Liposomal ATP partly maintained crypt proliferation but did not inhibit epithelial necroptosis nor improve mucosal morphology
The effect of ATP on ischaemic intestine was assessed by instillation of ATP-encapsulated or empty liposomes into Isch rats. Restoration of energy levels in gut mucosa was confirmed in ischaemic intestines given liposomal ATP (Fig. 5A) . Increased PCNA and ki67 immunoreactivity was observed in the crypt regions of ischaemic tissues after administration of liposomal ATP ( Fig. 4A and B) . Quantification results also showed that liposomal ATP reversed the ischaemia-induced decrease in the number of Ki67-positive cells per crypt (Fig. 4C) . However, liposomal ATP instillation did not reduce mucosal RIP1/3 complex formation (Fig. 5B) , nor did it improve the villus necrotic features and histopathological score in ischaemic tissues ( Fig. 5C and D) .
Effects of glucose, pyruvate and liposomal ATP on epithelial apoptosis caused by ischaemia
Apart from epithelial necroptosis, increased TUNELpositive apoptotic cells were also seen in ischaemic tissues (Fig. 6) . Enteral glucose and pyruvate reduced the number of apoptotic epithelial cells in ischaemic tissues to baseline control levels (Fig. 6) . However, liposomal ATP only partially decreased the apoptotic levels (Fig. 6 ).
Reperfusion injury and bacterial translocation were also ameliorated by glucose and pyruvate but not by non-metabolizable sugars
Lastly, the protective effect of glucose and pyruvate against reperfusion-associated mucosal injury and bacterial translocation was assessed in I/R rats subjected to mesenteric ischaemia for 20 min followed by reperfusion for 60 min. Villous dismantling, epithelial abnormality with widened intercellular junctions and enlarged cell-matrix gaps were observed following I/R ( Fig. 7A and B) . Subcellular necrotic features were seen, including mitochondrial swelling, cytoplasmic vacuolation and cytosol density loss ( Fig. 7C-E) . I/R enterocytes also displayed numerous apical regions denuded of microvilli; the microvilli that . Enteral instillation of glucose or pyruvate protected against epithelial apoptosis in an energy-independent manner in ischaemic gut Rats were subjected to sham operation as controls (CON) or mesenteric ischaemia (Isch). Isch rats were enterally instilled vehicle (veh), glucose (G), pyruvate (Pyr) or liposomal ATP (ATP) and epithelial apoptosis in intestinal tissues was measured using a TUNEL assay. The number of TUNEL-positive epithelial cells per villus was determined. * P < 0.05 vs. respective CON, # P < 0.05 vs. 'Isch + Veh' (n = 6 per group).
remained present were in the form of microsomes or sequential banding ( Fig. 7D and E) . Moreover, epithelial repair showing a flattened epithelium at the edge of denuded area as evidence of restitution during reperfusion was also seen in I/R rats (Fig. 7A) . The I/R-induced necrotic features and histopathology were abolished by enteral instillation of glucose or pyruvate ( Fig. 7A and  F) but not by non-metabolizable sugars (i.e. 3-OMG, mannitol) or amino acid (i.e. glutamate) (Fig. 7F and G) .
Intestinal permeability changes were evaluated by lumen-to-blood passage of fluorescein-conjugated dextran (molecular weight = 30,00) or monitored by portal influx of a contrast agent Gd (molecular weight = 574) using real-time MRI. I/R-increased intestinal permeability was reduced by enteral instillation of glucose or pyruvate but not by other non-metabolizable substances ( Fig. 8A and B) . Lastly, bacterial translocation to extraintestinal organs was used as an indicator of gut-derived sepsis. The bacterial counts in the liver and spleen tissues were significantly decreased by glucose and pyruvate (Fig. 8C) .
Discussion
The present study provides evidence of a novel form of necrotic death in ischaemic enterocytes that involves the assembly and phosphorylation of RIP1/3 complex. The ischaemia-induced epithelial cell death, loss of crypt proliferation and mucosal morphological damage are protected by enteral glucose uptake. Our data indicate that glucose metabolites (i.e. pyruvate and ATP) play distinct cytoprotective roles in ischaemic gut. Administration of pyruvate inhibited epithelial necroptotic death but did not rescue against crypt dysfunction, whereas replenishment of ATP partly restored crypt proliferation but failed to rescue cell necroptosis.
Abundant studies showed epithelial cell death (both apoptosis and necrosis) with widened cell-cell and cell-matrix gaps following I/R challenge, resulting in intestinal barrier dysfunction and bacterial translocation (Shah et al. 1997; Little et al. 2003; Azuara et al. 2005; Huang et al. 2011 ). Glucose instillation is well known for being protective against mucosal morphological and barrier damage caused by ischaemic insults; however, the detailed mechanisms responsible for this remain unclear (Kozar et al. 2002; Huang et al. 2011) . Anaerobic glycolytic pathway converts one glucose molecule to two pyruvates, which also generates two ATP through the process catalysed by pyruvate kinase. Pyruvate then feeds into the tricarboxylic acid cycle in mitochondrial respiration for oxygen-dependent ATP production (Huang & Yu, 2015) . In the present study, we assessed the protective effects of distinct glucose metabolites (pyruvate and ATP) on two aspects of ischaemia-induced epithelial injury, including cell death and crypt dysfunction. Our previous studies demonstrated that glucose uptake prevented caspase-dependent apoptosis in enterocytes after mesenteric I/R (Huang et al. 2011) . The data in the present study show that pyruvate attenuated the RIP1/3-dependent necroptosis in epithelial cells after ischaemic insults, whereas replenishment of ATP failed to modulate necroptotic epithelial death. On the other hand, the maintenence of crypt proliferation in ischaemic gut by glucose was recapitulated by the administration of liposomal ATP but not of pyruvate, suggesting that glucose metabolism and ATP synthesis restored crypt function. Although pyruvate is the starting substance in the tricarboxylate cycle, pyruvate instillation during ischaemia may not lead to ATP generation by mitochondrial respiration as a result of the low oxygen levels. Indeed, instillation of glucose during ischaemia increase tissue ATP levels but pyruvate did not. In addition to glucose metabolism, SGLT1-mediated signalling pathways such as PI3K/Akt and NF-κB (Palazzo et al. 2008; Huang et al. 2011 ) may also be involved in glucose-promoted epithelial renewal and proliferation. The present study is the first to tease out the specific site and modes of action for glucose metabolites to exert cytoprotection in ischaemic intestine. Numerous studies, including those in intestine and sterile organs, have attributed glucose-mediated cytoprotection against ischaemic injury to its ability for energy replenishment (Inci et al. 2001; Fu et al. 2014; Wei et al. 2014; Qi & Young, 2015) . However, unlike others showing beneficial effects of liposomal ATP to ischaemic injury in neurons, myocardiocytes and the retina (Dvoriantchikova et al. 2010; Levchenko et al. 2010; Liu et al. 2013 ), we did not see a reduction in histopathological score in intestinal ischaemia, despite partial restoration of crypt proliferation following ATP administration. This discrepancy may be a result of the severe epithelial cell death (which was not protected by ATP) leading to massive bacterial influx accompanied by inflammation and secondary tissue injury. Thus, ATP-promoting crypt proliferation was insufficient to alter the course of ischaemic injury.
In the present study, ATP-encapsulated liposomes were utilized for the direct delivery of ATP into epithelial cells in comparison to enteral nutrient-derived energy metabolism. Amino acids such as glutamine and glutamate are metabolic energy fuels that utilize the mitochondrial oxidative pathways of tricarboxylic acid cycle for ATP synthesis (Fleming et al. 1997; Reeds et al. 2000) . The use of liposomal ATP delivery instead of metabolic energy fuels aimed to ensure that cells acquire ATP even if mitochondrial oxidative phosphorylation was shut down during ischaemic/hypoxic conditions. Compared to pyruvate, glutamate did not reduce mucosal histopathology, epithelial permeability or bacterial translocation in I/R rats in the present study. Glutamate serves as a valuable control for glycolytic pyruvate because both enter the mitochondrial tricarboxylic acid cycle under normoxic conditions. We suspect that, in the ischaemic/hypoxic condition, both substrates did not undergo mitochondria-dependent oxidative energy metabolism, further indicating that epithelial death resistance by pyruvate was uncoupled from ATP production. Furthermore, abundant studies have shown that glutamine protects against epithelial barrier function and bacterial translocation in rodent and porcine models of intestinal I/R (Blikslager et al. 1999; Kozar et al. 2002; Kozar et al. 2004a; Sato et al. 2005; Medeiros et al. 2006) . Unpublished data obtained in our laboratory also show that enteral instillation of glutamine reduced epithelial barrier dysfunction in I/R rats (CY Huang and LCH Yu, unpublished data). However, the protective effects of glutamine have been attributed to two factors, which include serving as an oxidative metabolic fuel and acting as an immune-enhancing agent (Kozar et al. 2004b; Sato et al. 2005) . Therefore, we did not conduct further experiments to study the effect of glutamine on epithelial necroptosis because of its immunomodulatory role, which might confound data interpretation.
Our previous study indicated that pyruvate scavenges mitochondrial free radicals and inhibits necroptosis in hypoxic cells (Huang et al. 2013) . In the present study, we showed that pyruvate inhibited epithelial necroptosis during ischaemia, and also prevented epithelial permeability increase and bacterial translocation after of glucose. Magnification 200×. B, representative electromicrographs showing I/R-induced ultrastructural damage in epithelial cells may be prevented by glucose. Compared to the tightly linked columnar cells with lumen (L)-facing long brush border (BB) in sham controls, I/R enterocytes exhibited round-shape morphology with effacing microvilli, widened intercellular junctions (arrowhead) and enlarged cell-matrix gaps ( # ). The I/R-induced epithelial damage was ameliorated by glucose instillation. The cell nucleus (N) was also labelled in images. C, higher magnification of I/R enterocytes showing subcellular abnormalities, including mitochondrial (M) swelling, cytoplasmic vacuolation ( * ) and cytosol density loss (ˆ). D and E, higher magnification of I/R enterocytes displayed widened intercellular junctions (arrowhead) and numerous apical regions denuded of microvilli, and those that remain present are in the form of sequential constrictions, and often appeared to be disintegrating into microsomes. blood reperfusion. The results are in keeping with early reports demonstrating that I.V. and intraluminal administration of ethyl pyruvate or sodium pyruvate attenuated reperfusion-induced oxidative free radical levels and prevented mucosal barrier dysfunction (Cicalese et al. 1996; Sims et al. 2001; Cruz et al. 2011; Petrat et al. 2011) . Together with our studies, these findings suggest that the anti-oxidant characteristics of glycolytic pyruvate The intestinal permeability of sham-operated (Sham) and ischaemia/reperfusion (I/R) rats with or without enteral instillation of glucose (G) and pyruvate (Pyr) was assessed. A, 4-kDa FITC-dextran (FD4) concentration in plasma sample collected from sham, I/R + w/o, I/R + G and I/R + Pyr rats at 60 min post-reperfusion. A significant increase of lumen-to-blood passage of FD4 was seen in I/R rats compared to sham controls, which was decreased by instillation of glucose and pyruvate. B, increased the signal-to-noise ratio (SNR) of Gd in the liver (Ba) and the Gd concentration in plasma samples (Bb) was found in I/R rats compared to Sham rats, suggesting enhanced portal drainage of enterally administered Gd after reperfusion. Enteral instillation of glucose but not 3-OMG mannitol or glutamate reduced the increase of liver, kidney and plasma signals. Statistical labels were omitted for clarity (n = 6 per group). C, bacterial counts in liver and spleen were determined in Sham and I/R rats. Each data point represents the bacterial CFU from one animal, and the median values are shown as bars. The increase in liver and spleen bacterial counts in I/R rats was reduced by enteral instillation of glucose and pyruvate but not other substances (i.e. 3-OMG, mannitol or glutamate). * P < 0.05 vs. sham; # P < 0.05 vs. 'I/R + w/o' (n = 6-8 per group).
may underlie the mechanisms of its protection against ischaemia-and reperfusion-induced epithelial cell death.
Although concerns were raised regarding whether glucose uptake and glycolytic ATP may cause a switch from necrosis to apoptosis, as previously shown in ischaemic hepatocytes (Kim et al. 2003) , our previous and current data show a decrease in apoptotic levels after glucose and pyruvate instillation in ischaemic gut (Huang et al. 2011) . In addition, glucose and pyruvate attenuated necroptosis and apoptotic death in an ATP-independent manner. Taken together, it is plausible that glucose and pyruvate (uncoupled from ATP) are capable of preventing ischaemic cells from undergoing either class of programmed cell death, rather than inducing a mode switch.
Upon facing metabolic and oxidative crisis (e.g. hypoxia and nutrient deprivation), different modes and orders of cell death including apoptosis, necroptosis or necrosis, may occur (Huang & Yu, 2015) . In the present study, prolonged ischaemia after 60-120 min resulted in RIP-independent epithelial necrosis, which could not be protected by enteral instillation of glucose or pyruvate (data not shown). It remains unclear whether cell death modes occur in a sequential or overlapping order, and controversial data exist regarding the critical trigger(s) responsible for each death mode or for mode switching (i.e. sensing of oxygen drop, energy depletion or acidity increase) (Taylor, 2008; Chandel, 2010; Holzer, 2011) . Our study challenges the notion that energy depletion is the initiating factor for triggering cell death under ischaemic stress. Overall, glycolytic pyruvate uncoupled from energy synthesis played a protective role against various modes of programmed cell death (i.e. apoptosis and necroptosis).
In conclusion, glucose metabolites play distinct cytoprotective roles in intestinal ischaemia. Pyruvate attenuated epithelial necroptosis and apoptosis in an ATP-independent manner, whereas energy replenishment partially restored crypt proliferation but did not prevent cell death in ischaemic gut. Our data argue against the traditional view of ATP as the main cytoprotective factor by enteral glucose metabolism, and indicate a novel anti-necroptotic role of glycolytic pyruvate under ischaemic stress.
